NT-proBNP and atrioventricular plane displacement. Relationship and diagnostic implications;NT-proBNP y desplazamiento del plano auriculoventricular. Relación e implicaciones diagnósticas

Revista Espanola de Cardiologia

Volumn 56, Issue 11, 2003, Pages 1043-1049

  Rivera Otero, Miguel ^a,k   Cortés, Raquel ^a   Mora, Vicente ^b   Miró, Vicente ^a   Cosín, Juan ^a   Jordán, Alejandro ^e   García de Burgos, Fernando ^e   Salvador, Antonio ^b   Sogorb, Francisco ^g   Marín, Francisco ^g   Climent, Vicente ^g   Bertomeu, Vicente ^d   Frutos, Araceli ^d   Taléns, Raquel ^a   Payá, Rafael ^f   Pérez Boscá, José L ^f   Diago, José L ^c   Hernandiz A ^a   Capdevila, C ^a   Roldan, I ^b   Moreno, J ^c   Guallar, C ^c   Ibanez A ^g   Valencia, J ^g   Grau, G ^h   Mainar, L ⁱ   Gomez R ⁱ   Marti, S ^j   more..

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^d HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^h Hospital General Alcoy   (Spain)

ⁱ Hospital de Requena   (Spain)

^j Hospital de la Marina Alta de Denia   (Spain)

^k Hospital de la Marina Alta de Denia ^*  (Spain)

more..

Author keywords

Echocardiography; Heart failure; Natriuretic peptides

Indexed keywords

NATRIURETIC FACTOR;

AGED; ARTICLE; CLINICAL PRACTICE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC TEST; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; FEMALE; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PROTEIN BLOOD LEVEL; SPAIN;

EID: 9144222003     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13054029     Document Type: Article

References (32)

1. Ericksson H. Heart failure: a growing public health problem. J Intern Med 1995;237:135-41.
2. Cosín J, Cruz JM, De Teresa E, Ferreira U, López J, Soler J, et al. Factores neurohormonales en la insuficiencia cardíaca (II). Rev Esp Cardiol 1996;49:317-27.
3. Kelly R, D Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure? Ann Clin Biochem 2001;38:94-102.
4. Sagnella G. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998;95:519-29.
5. Vidal B, Roig E, Pérez-Villa F, Orús J, Pérez J, Jiménez V, et al. Valor pronóstico de los niveles de citocinas y neurohormonas en la insuficiencia cardíaca severa. Rev Esp Cardiol 2002;55:481-6.
6. Alejandro Salomone O. Los péptidos natriuréticos en la insuficiencia cardíaca: mejorando el diagnóstico y el manejo del síndrome. Rev Esp Cardiol 2002;55:4-6.
7. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet 1998;351:9-13.
8. Cowie MR, Struthers AD, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assesment of patients with possible new heart failure in primary care. Lancet 1997;350:1347-51.
9. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.
10. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
11. Sudoh T, Kangawak K, Minamino N, Matsuo M. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
12. Stein BC, Levin RI. Natriuretic peptides physiology, therapeutic potencial, and risk stratification in ischemic heart disease. Am Heart J 1998;135:914-23.
13. Talwar S, Siebenhofer A, Williams B, Ng L. Influence of hypertension, left ventricular hypertrophy and left ventricular systolic dysfunction on plasma N-terminal proBNP. Heart 2000;83:278-82.
14. Luchner A, Hengstenberg C, Löwel H, Trawinski J, Baumann M, Riegger AJ, et al. N-terminal pro-brain natriuretic peptide after myocadial infarction. A marker of cardio-renal function. Hypertension 2002;39:99-104.
15. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Inmunoreactive amino-terminal pro-brain natriuretic peptide (NT-ProBNP): a new marker of cardiac impairment. Clin Endocrinol 1997;47:287-96.
16. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, et al. Plasma N-probrain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9.
17. Talwar S, Squire IB, Davies JE, Barnett DB, Ng LL. Plasma N-terminal pro-brain natriuretic peptide and de ECG in the assessment of left ventricular systolic dusfunction in a high risk population. Eur Heart J 1999;20:1736-44.
18. Campbell DJ, Munir V, Hennessy OF, Dent AW. Plasma amino-terminal pro-brain natriuretic peptide levels in subjects presenting to the emergency department with suspected acute coronary syndrome: possible role in selecting patients for follow up? Intern Med J 2001;31:211-9.
19. Kranidis A, Kostopoulos K, Anthopoulos L. Evaluation of left ventricular filling by echocardiographic atrioventricular plane displacement in patients with ischemic heart disease. Int J Cardiol 1995;48:183-6.
20. Willenheimer R, Cline C, Erhardt L, Israelsson B. Left ventricular atrioventricular plane displacement: an echocardiographic technique for rapid assessment of prognosis in heart failure. Heart 1997;78:230-6.
21. Willenheimer R, Israelsson B, Cline C, Rydberg E, Broms K, Erhardt L. Left atrioventricular plane displacement is related to both systolic and diastolic left ventricular performance in patients with chronic heart failure. Eur Heart J 1999;20:612-8.
22. Greim CA, Broscheit JA, Lorenz KW, Thiel H, Roewer N. Intracavitary contrast intensity after transpulmonary transmission of a second-generation contrast agent at normal and reduced myocardial contractility. J Am Soc Echocardiogr 2000;13: 1030-7.
23. Sieswerda GT, Kamp O, van den Ende R, Visser CA. Intermittent harmonic imaging and videodensitometry significantly enhance ability of intravenous air-filled ultrasonographic contrast agent to produce ventricular and myocardial opacification. J Am Soc Echocardiogr 2001;14:20-8.
24. Tsujita-Kuroda Y, Zhang G, Sumita Y, Hirooka K, Hanatani A, Nakatani S, et al. Validity and reproducibility of echocardiographic measurement of left ventricular ejection fraction by acoustic quantification with tissue harmonic imaging technique. J Am Soc Echocardiogr 2000;13:300-5.
25. Vancon AC, Fox ER, Chow CM, Hill J, Weyman AE, Picard MH, et al. Pulse inversion harmonic imaging improves endocardial border visualization in two-dimensional images: comparison with harmonic imaging. J Am Soc Echocardiogr 2002; 15:302-8.
26. Cosin J, Asin E, Marrugat J, Elosua R, Aros F, de los Reyes M, et al. Prevalence of angina pectoris in Spain. PANES Study group. Eur J Epidemiol 1999;15:323-30.
27. García MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998;32:865-75.
28. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
29. Alam M, Höglund C. Serial echocardiographic studies following thrombolytic treatment in myocardial infarction with special reference to the atrioventricular valve plane displacement. Clin Cardiol 1992;15:30-6.
30. Osca J, Quesada. A, Arnau MA, Osa A, Hervás I, Almenar L, et al. Péptido cerebral natriurético. Valor diagnóstico en la insuficiencia cardíaca. Rev Esp Cardiol 2002;55:7-15.
31. Brookes CI, Kemp MW, Hooper J, Oldershaw PJ, Moat NE. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 1997;6:608-12.
32. Gerber IL, Ralph AHS, French R, Legget ME, Greaves SC, Sutton TM, et al. Natriuretic peptides are elevated in aortic regurgitation but correlate poorly with disease severity [abstract]. J Am Coll Cardiol 2002;39(Suppl B):350.